Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Tetanus Toxoid"" wg kryterium: Temat


Tytuł :
Clinical Decision Support Reduces Unnecessary Tetanus Vaccinations in the Emergency Department.
Autorzy :
Dutta S; Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA; Massachusetts General Brigham Digital Health, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: .
McEvoy DS; Massachusetts General Brigham Digital Health, Boston, MA.
Stump T; Massachusetts General Brigham Digital Health, Boston, MA.
McCabe J; Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA; Massachusetts General Brigham Digital Health, Boston, MA.
Mahendra-Rajah A; Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA.
McMurry R; Boston University School of Medicine, Boston, MA.
White BA; Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA.
Rubins D; Massachusetts General Brigham Digital Health, Boston, MA.
Pokaż więcej
Źródło :
Annals of emergency medicine [Ann Emerg Med] 2021 Sep; Vol. 78 (3), pp. 370-380. Date of Electronic Publication: 2021 May 08.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Immunization Schedule*
Decision Support Systems, Clinical/*standards
Tetanus Toxoid/*administration & dosage
Vaccination/*statistics & numerical data
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Emergency Service, Hospital/statistics & numerical data ; Female ; Humans ; Male ; Middle Aged ; Non-Randomized Controlled Trials as Topic ; Quality Improvement ; Retrospective Studies ; Tetanus Toxoid/adverse effects ; Tetanus Toxoid/immunology ; Unnecessary Procedures ; Young Adult
Czasopismo naukowe
Tytuł :
Plasma cell immunoglobulin heavy chain repertoire dynamics before and after tetanus booster vaccination.
Autorzy :
Wolf KJ; Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, 63104, USA.; ArcherDX, Inc., Boulder, CO, 80301, USA.
Adeyemo AA; Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20814, USA.
Williamson KC; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA. .
Pokaż więcej
Źródło :
Immunogenetics [Immunogenetics] 2021 Aug; Vol. 73 (4), pp. 321-332. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Complementarity Determining Regions/*genetics
Immunoglobulin Heavy Chains/*genetics
Immunoglobulin Heavy Chains/*immunology
Leukocytes, Mononuclear/*immunology
Plasma Cells/*immunology
Tetanus Toxoid/*immunology
Vaccination/*methods
Complementarity Determining Regions/immunology ; Healthy Volunteers ; Humans ; Leukocytes, Mononuclear/metabolism ; Tetanus Toxoid/administration & dosage
Czasopismo naukowe
Tytuł :
Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial.
Autorzy :
Qadri F; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Electronic address: .
Khanam F; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Theiss-Nyland K; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Biswas PK; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Bhuiyan AI; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Ahmmed F; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Colin-Jones R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Smith N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Tonks S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Mazur O; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Rajib NH; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Hossen MI; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Ahmed SU; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Khan A; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Rahman N; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Babu G; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Kelly S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Ireen M; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Islam K; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
O'Reilly P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Scherrer KS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Pitzer VE; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT USA.
Neuzil KM; University of Maryland School of Medicine, Baltimore MD, USA.
Zaman K; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Clemens JD; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh; University of California Los Angeles, Fielding School of Public Health, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Aug 21; Vol. 398 (10301), pp. 675-684. Date of Electronic Publication: 2021 Aug 09.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Vaccination*
Polysaccharides, Bacterial/*administration & dosage
Tetanus Toxoid/*therapeutic use
Typhoid Fever/*prevention & control
Typhoid-Paratyphoid Vaccines/*administration & dosage
Vaccines, Conjugate/*administration & dosage
Adolescent ; Bangladesh/epidemiology ; Child ; Child, Preschool ; Developing Countries ; Encephalitis, Japanese/epidemiology ; Female ; Humans ; Infant ; Japanese Encephalitis Vaccines/administration & dosage ; Male ; Salmonella typhi/immunology ; Tetanus Toxoid/immunology ; Typhoid Fever/epidemiology ; Typhoid Fever/immunology
Czasopismo naukowe
Tytuł :
Enhancement of immunopotentiation using tetanus toxoid-based nanoparticulate dissolvable microneedles.
Autorzy :
Waghchaure M; Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS, V. L. Mehta Road, Vile Parle (W), Mumbai, India.
Govardhane S; Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS, V. L. Mehta Road, Vile Parle (W), Mumbai, India.
Shende P; Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS, V. L. Mehta Road, Vile Parle (W), Mumbai, India. .
Pokaż więcej
Źródło :
Biomedical microdevices [Biomed Microdevices] 2021 Jun 28; Vol. 23 (3), pp. 32. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :
Journal Article
MeSH Terms :
Nanoparticles*
Tetanus Toxoid*
Animals ; Drug Delivery Systems ; Mice ; Mice, Inbred BALB C ; Needles
Czasopismo naukowe
Tytuł :
Regional disparities and their contribution to the coverage of the tetanus toxoid vaccine among women aged 15-49 years in Indonesia.
Autorzy :
Arifin H; Department of Medical-Surgical Nursing, Faculty of Nursing, Universitas Padjadjaran, Bandung, Indonesia.
Widiasih R; Department of Maternity Nursing, Faculty of Nursing, Universitas Padjadjaran, Bandung, Indonesia.
Pradipta RO; Faculty of Nursing, Universitas Airlangga, Surabaya, Indonesia.
Kurniawati Y; Department of Medical-Surgical Nursing, Faculty of Nursing, Universitas Padjadjaran, Bandung, Indonesia.
Pokaż więcej
Źródło :
F1000Research [F1000Res] 2021 Jun 03; Vol. 10, pp. 437. Date of Electronic Publication: 2021 Jun 03 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Tetanus*/prevention & control
Tetanus Toxoid*
Female ; Health Education ; Humans ; Indonesia ; Logistic Models
Czasopismo naukowe
Tytuł :
Factors associated with births protected against neonatal tetanus in Africa: Evidences from Demographic and health surveys of five African countries.
Autorzy :
Yeshaw Y; Department of Physiology, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Jemere T; Department of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Dagne H; Department of Environmental and Occupational Health and Safety, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Andualem Z; Department of Environmental and Occupational Health and Safety, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Akalu Y; Department of Physiology, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Dewau R; Department of Epidemiology and Biostatistics, School of Public Health, College of Medicine and Health sciences, Wollo University, Dessie, Ethiopia.
Teshale AB; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Tesema GA; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Dagnew B; Department of Physiology, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Jun 17; Vol. 16 (6), pp. e0253126. Date of Electronic Publication: 2021 Jun 17 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Tetanus Toxoid*
Tetanus/*prevention & control
Adult ; Africa ; Age Factors ; Educational Status ; Female ; Health Services Accessibility ; Health Surveys ; Humans ; Infant, Newborn ; Male ; Middle Aged ; Pregnancy ; Prenatal Care ; Socioeconomic Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates.
Autorzy :
Hong SH; Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Oh H; National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Chungcheongbuk, Republic of Korea.
Park YW; Department of Research and Development, SK Bioscience, Pangyoro 332, Bundang-gu, Republic of Korea.
Kwak HW; Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Oh EY; Division of Biotechnology, College of Environmental and Bioresources, Jeonbuk National University, Iksan 54596, Republic of Korea.
Park HJ; Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Kang KW; Division of Biotechnology, College of Environmental and Bioresources, Jeonbuk National University, Iksan 54596, Republic of Korea.
Kim G; National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Chungcheongbuk, Republic of Korea.
Koo BS; National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Chungcheongbuk, Republic of Korea.
Hwang EH; National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Chungcheongbuk, Republic of Korea.
Baek SH; National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Chungcheongbuk, Republic of Korea.
Park HJ; Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Lee YS; Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Bang YJ; Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Kim JY; Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Bae SH; Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
Lee SJ; Department of Research and Development, SK Bioscience, Pangyoro 332, Bundang-gu, Republic of Korea.
Seo KW; Department of Research and Development, SK Bioscience, Pangyoro 332, Bundang-gu, Republic of Korea.
Kim H; Department of Research and Development, SK Bioscience, Pangyoro 332, Bundang-gu, Republic of Korea.
Kwon T; Department of Research and Development, SK Bioscience, Pangyoro 332, Bundang-gu, Republic of Korea.
Kim JH; Department of Research and Development, SK Bioscience, Pangyoro 332, Bundang-gu, Republic of Korea.
Lee S; Department of Research and Development, SK Bioscience, Pangyoro 332, Bundang-gu, Republic of Korea.
Kim E; Department of Research and Development, SK Bioscience, Pangyoro 332, Bundang-gu, Republic of Korea.
Kim Y; Division of Biotechnology, College of Environmental and Bioresources, Jeonbuk National University, Iksan 54596, Republic of Korea.
Park JH; Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
Park SI; Scripps Korea Antibody Institute, Chuncheon, Kangwon-do 24341, Republic of Korea.
Gonçalves M; Soft Matter Physics Laboratory, School of Advanced Materials Science and Engineering, SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University, Suwon 16419, Republic of Korea.
Weon BM; Soft Matter Physics Laboratory, School of Advanced Materials Science and Engineering, SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University, Suwon 16419, Republic of Korea.
Jeong H; Severance Biomedical Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
Nam KT; Severance Biomedical Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
Hwang KA; Department of Research and Development, SML Genetree, Baumero 225, Seocho-gu, Seoul 06740, Republic of Korea.
Kim J; Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin 17104, Republic of Korea.
Kim H; Department of Research and Development, SK Bioscience, Pangyoro 332, Bundang-gu, Republic of Korea.
Lee SM; Present address: College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea. />Hong JJ; National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Chungcheongbuk, Republic of Korea. .
Nam JH; Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea. .
Pokaż więcej
Źródło :
Science advances [Sci Adv] 2021 May 28; Vol. 7 (22). Date of Electronic Publication: 2021 May 28 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*prevention & control
COVID-19 Vaccines/*immunology
Coronavirus Nucleocapsid Proteins/*immunology
Recombinant Fusion Proteins/*immunology
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Tetanus Toxoid/*immunology
Animals ; COVID-19/genetics ; COVID-19/immunology ; COVID-19 Vaccines/genetics ; Chlorocebus aethiops ; Coronavirus Nucleocapsid Proteins/genetics ; Female ; Macaca fascicularis ; Mice ; Mice, Inbred BALB C ; Mice, Transgenic ; Phosphoproteins/genetics ; Phosphoproteins/immunology ; Protein Domains ; Rats ; Recombinant Fusion Proteins/genetics ; SARS-CoV-2/genetics ; Sf9 Cells ; Spike Glycoprotein, Coronavirus/genetics ; Spodoptera ; Tetanus Toxoid/genetics ; Vero Cells
Czasopismo naukowe
Tytuł :
Evaluation of Immune and Vaccine Competence in Steroid-Sensitive Nephrotic Syndrome Pediatric Patients.
Autorzy :
Colucci M; Renal Diseases Research Unit, Genetics and Rare Diseases Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Piano Mortari E; Diagnostic Immunology Research Unit, Multimodal Medicine Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Zotta F; Division of Nephrology, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Corrente F; Diagnostic Immunology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Concato C; Division of Virology, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Carsetti R; Diagnostic Immunology Research Unit, Multimodal Medicine Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.; Diagnostic Immunology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Emma F; Renal Diseases Research Unit, Genetics and Rare Diseases Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.; Division of Nephrology, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Vivarelli M; Renal Diseases Research Unit, Genetics and Rare Diseases Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.; Division of Nephrology, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Mar 12; Vol. 12, pp. 602826. Date of Electronic Publication: 2021 Mar 12 (Print Publication: 2021).
Typ publikacji :
Clinical Trial; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Bacterial*/blood
Antibodies, Bacterial*/immunology
Hepatitis B Antibodies*/blood
Hepatitis B Antibodies*/immunology
Hepatitis B Vaccines*/administration & dosage
Hepatitis B Vaccines*/immunology
Immunoglobulin G*/blood
Immunoglobulin G*/immunology
Nephrotic Syndrome*/blood
Nephrotic Syndrome*/immunology
Tetanus Toxoid*/administration & dosage
Tetanus Toxoid*/immunology
Child ; Child, Preschool ; Female ; Humans ; Male ; Steroids
Czasopismo naukowe
Tytuł :
Adjustments for oral fluid quality and collection methods improve prediction of circulating tetanus antitoxin: Approaches for correcting antibody concentrations detected in a non-invasive specimen.
Autorzy :
Garrison-Desany H; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Ochieng BO; Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Kisumu, Kenya.
Odiere MR; Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Kisumu, Kenya.
Kuo H; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Gibson DG; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Were J; Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Kisumu, Kenya.
Kagucia EW; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Pasetti MF; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Kim H; Global Health, Bill & Melinda Gates Foundation, Seattle, WA, USA.
Reymann M; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
O'Brien K; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Hayford K; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jan 08; Vol. 39 (2), pp. 423-430. Date of Electronic Publication: 2020 Nov 27.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Tetanus Antitoxin*
Tetanus Toxoid*
Adolescent ; Antibodies, Bacterial ; Child ; Cross-Sectional Studies ; Humans ; Immunoglobulin G ; Mouth
Czasopismo naukowe
Tytuł :
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs . a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study.
Autorzy :
van der Vliet D; Sanofi Pasteur, Marcy l'Etoile, France.
Vesikari T; Vaccine Research Center, University of Tampere, Tampere, Finland.
Sandner B; NETSTAP (Network of children's physicians for clinical trials in the ambulant pediatrics), Aschaffenburg, Germany.
Martinón-Torres F; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; Genetics, Vaccines and Pediatrics Research Group, University of Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Muzsay G; Gyor-Marcal Város II. sz. Gyermekorvosi Rendelő, Pediatrics, Győr, Hungary.
Forsten A; Vaccine Research Center, University of Tampere, Tampere, Finland.
Adelt T; Pediatric practice, Bramsche, in cooperation with NETSTAP (Network of Children's Physicians for clinical trials in the ambulant pediatrics), Germany.
Diaz Gonzalez C; Hospital Universitario La Paz, Madrid, Spain.
Simko R; Futurenest Clinical Research, Miskolc, Hungary.
B'Chir S; Sanofi Pasteur, Marcy l'Etoile, France.
Neveu D; Sanofi Pasteur, Swiftwater, PA, USA.
Jordanov E; Sanofi Pasteur, Swiftwater, PA, USA.
Dhingra MS; Sanofi Pasteur, Swiftwater, PA, USA.
Pokaż więcej
Źródło :
Epidemiology and infection [Epidemiol Infect] 2021 Feb 05; Vol. 149, pp. e50. Date of Electronic Publication: 2021 Feb 05.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Meningococcal Vaccines/*immunology
Tetanus Toxoid/*immunology
Europe ; Female ; Finland ; Humans ; Infant ; Male ; Meningococcal Infections/prevention & control ; Meningococcal Vaccines/administration & dosage ; Tetanus/prevention & control ; Tetanus Toxoid/administration & dosage ; Vaccines, Combined
Czasopismo naukowe
Tytuł :
Generalized, non-neonatial tetanus is a highly fatal disease in Afghanistan: A case series study.
Autorzy :
Qaderi S; Department of Communicable Disease, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Communicable Disease, Kabul Antani Hospital, Kabul University of Medical Sciences, Kabul, Afghanistan. Electronic address: .
Qaderi F; Department of Communicable Disease, Emam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: .
Tarki FE; Department of Internal Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: .
Shah J; Drexel University College of Medicine, Pennsylvania, USA. Electronic address: .
Afaghi S; Department of Internal Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: .
Delsoz M; Department of Communicable Disease, Kabul Antani Hospital, Kabul University of Medical Sciences, Kabul, Afghanistan. Electronic address: .
Shah A; Division of Biology and Medicine, Brown University, Providence, Rhode Island, USA. Electronic address: .
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Feb; Vol. 103, pp. 568-572. Date of Electronic Publication: 2020 Dec 16.
Typ publikacji :
Journal Article
MeSH Terms :
Tetanus/*epidemiology
Tetanus/*pathology
Tetanus Toxoid/*pharmacology
Adolescent ; Adult ; Afghanistan/epidemiology ; Aged ; Animals ; Bites and Stings/complications ; Delivery of Health Care ; Dogs ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Substance Abuse, Intravenous/complications ; Tetanus/diagnosis ; Tetanus/prevention & control ; Tetanus Toxoid/administration & dosage ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
A case of recurrent sterile abscesses following tetanus-diphtheria vaccination treated with corticosteroids.
Autorzy :
Kaya A; Department of Infectious Diseases, İstanbul Training and Research Hospital, Istanbul, Turkey. .
Kaya SY; Infectious Diseases Unit, Sungurlu State Hospital, Çorum, Turkey.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Jan 12; Vol. 21 (1), pp. 53. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Abscess/*drug therapy
Abscess/*etiology
Adrenal Cortex Hormones/*administration & dosage
Diphtheria Toxoid/*adverse effects
Tetanus Toxoid/*adverse effects
Abscess/diagnostic imaging ; Adult ; Diphtheria Toxoid/administration & dosage ; Female ; Humans ; Tetanus Toxoid/administration & dosage ; Ultrasonography ; Young Adult
Czasopismo naukowe
Tytuł :
Broadly protective semi-synthetic glycoconjugate vaccine against pathogens capable of producing poly-β-(1→6)-N-acetyl-d-glucosamine exopolysaccharide.
Autorzy :
Gening ML; Laboratory of Glycoconjugate Chemistry, N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, 119991 Moscow, Russia.
Pier GB; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA 02115, USA. Electronic address: .
Nifantiev NE; Laboratory of Glycoconjugate Chemistry, N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, 119991 Moscow, Russia. Electronic address: .
Pokaż więcej
Źródło :
Drug discovery today. Technologies [Drug Discov Today Technol] 2020 Dec; Vol. 35-36, pp. 13-21. Date of Electronic Publication: 2020 Oct 26.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Bacterial Infections/*prevention & control
Bacterial Vaccines/*administration & dosage
Polysaccharides, Bacterial/*immunology
Tetanus Toxoid/*administration & dosage
beta-Glucans/*administration & dosage
Animals ; Bacterial Infections/immunology ; Bacterial Infections/microbiology ; Bacterial Vaccines/chemical synthesis ; Bacterial Vaccines/immunology ; Disease Models, Animal ; Glycoconjugates/administration & dosage ; Glycoconjugates/chemical synthesis ; Glycoconjugates/immunology ; Humans ; Immunogenicity, Vaccine ; Polysaccharides, Bacterial/administration & dosage ; Polysaccharides, Bacterial/chemical synthesis ; Tetanus Toxoid/chemical synthesis ; Tetanus Toxoid/immunology ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/chemistry ; Vaccines, Synthetic/immunology ; beta-Glucans/chemical synthesis ; beta-Glucans/immunology
Czasopismo naukowe
Tytuł :
Inactivated tetanus as an immunological smokescreen: A major step towards harnessing tetanus-based therapeutics.
Autorzy :
McLean T; Bioscience and Food Technology, School of Science, Plenty Road, Building 223 Bundoora West campus, RMIT University, Bundoora, VIC 3083, Australia. Electronic address: .
Norbury L; Bioscience and Food Technology, School of Science, Plenty Road, Building 223 Bundoora West campus, RMIT University, Bundoora, VIC 3083, Australia. Electronic address: .
Conduit R; School of Health and Biomedical Sciences, College of Science, Engineering and Health, RMIT University, Bundoora, VIC 3083, Australia. Electronic address: .
Shepherd N; Bioscience and Food Technology, School of Science, Plenty Road, Building 223 Bundoora West campus, RMIT University, Bundoora, VIC 3083, Australia.
Coloe P; Bioscience and Food Technology, School of Science, Plenty Road, Building 223 Bundoora West campus, RMIT University, Bundoora, VIC 3083, Australia. Electronic address: .
Sasse A; Bioscience and Food Technology, School of Science, Plenty Road, Building 223 Bundoora West campus, RMIT University, Bundoora, VIC 3083, Australia; Latrobe Regional Hospital, Gippsland, Australia. Electronic address: .
Smooker P; Bioscience and Food Technology, School of Science, Plenty Road, Building 223 Bundoora West campus, RMIT University, Bundoora, VIC 3083, Australia. Electronic address: .
Pokaż więcej
Źródło :
Molecular immunology [Mol Immunol] 2020 Nov; Vol. 127, pp. 164-174. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Tetanus Toxoid/*immunology
Tetanus Toxoid/*therapeutic use
Animals ; Humans ; Mice, Inbred C57BL ; Recombinant Proteins/isolation & purification ; Solutions ; Tetanus/immunology ; Tetanus Toxoid/administration & dosage ; Vaccination
Czasopismo naukowe
Tytuł :
Predictive modeling for assessing the long-term thermal stability of a new fully-liquid quadrivalent meningococcal tetanus toxoid conjugated vaccine.
Autorzy :
Neyra C; Manufacturing Technology Department, Sanofi Pasteur, Swiftwater, PA, USA. Electronic address: .
Clénet D; Bioprocess R&D Department, Sanofi Pasteur, Marcy l'Etoile, France. Electronic address: .
Bright M; Quality Control Stability, Sanofi Pasteur, Swiftwater, PA, USA. Electronic address: .
Kensinger R; Bioprocess R&D Department, Sanofi Pasteur, Swiftwater, PA, USA.
Hauser S; Manufacturing Technology Department, Sanofi Pasteur, Swiftwater, PA, USA. Electronic address: .
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2021 Nov 20; Vol. 609, pp. 121143. Date of Electronic Publication: 2021 Sep 29.
Typ publikacji :
Journal Article
MeSH Terms :
Meningococcal Infections*
Meningococcal Vaccines*
Antibodies, Bacterial ; Humans ; Tetanus Toxoid ; Vaccines, Combined ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Squirrelling the patient away.
Autorzy :
Deol P; Emergency Department, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK .
Woodman-Smith B; Emergency Department, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Earby M; Emergency Department, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło :
Emergency medicine journal : EMJ [Emerg Med J] 2021 Nov; Vol. 38 (11), pp. 829-841.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Sciuridae*
Bites and Stings/*complications
Tetanus Toxoid/*adverse effects
Adult ; Animals ; Drug-Related Side Effects and Adverse Reactions ; Female ; Humans ; Injection Site Reaction/complications ; Point-of-Care Systems ; Shoulder Pain/etiology ; Ultrasonography/methods
Czasopismo naukowe
Tytuł :
Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination.
Autorzy :
Vadrevu KM; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India.
Raju D; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India.
Rani S; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India.
Reddy S; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India.
Sarangi V; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India.
Ella R; Bharat Biotech International Limited, Genome Valley, Shameerpet, Hyderabad, India. Electronic address: .
Javvaji B; Sri Srinivasa Children's Hospital, Vijayawada, India.
Mahantshetty NS; Priya Children's Hospital, Vijayawada, India.
Battu S; KLE Hospital, Belgavi, India.
Levine MM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, USA.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Oct 29; Vol. 39 (45), pp. 6682-6690. Date of Electronic Publication: 2021 Oct 05.
Typ publikacji :
Journal Article
MeSH Terms :
Typhoid Fever*
Typhoid-Paratyphoid Vaccines*
Antibodies, Bacterial ; Antibody Formation ; Child ; Child, Preschool ; Humans ; Immunization, Secondary ; Polysaccharides ; Salmonella typhi ; Tetanus Toxoid ; Vaccination ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Diphtheria And Tetanus Vaccination History Is Associated With Lower Odds of COVID-19 Hospitalization.
Autorzy :
Monereo-Sánchez J; School of Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, Netherlands.
Luykx JJ; Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Outpatient Second Opinion Clinic, GGNet Mental Health, Warnsveld, Netherlands.
Pinzón-Espinosa J; Department of Mental Health, Parc Tauli University Hospital, Sabadell, Barcelona, Spain.; Department of Clinical Psychiatry, School of Medicine, University of Panama, Panama, Panama.; Department of Medicine, School of Medicine, University of Barcelona, Barcelona, Spain.
Richard G; NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Motazedi E; NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Westlye LT; NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Psychology, University of Oslo, Oslo, Norway.
Andreassen OA; NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
van der Meer D; NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Oct 07; Vol. 12, pp. 749264. Date of Electronic Publication: 2021 Oct 07 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Vaccination*
COVID-19/*immunology
Pertussis Vaccine/*immunology
SARS-CoV-2/*immunology
Tetanus Toxoid/*immunology
Aged ; COVID-19/pathology ; Female ; Humans ; Male ; Middle Aged ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
WHO recommendation and India's practice on tetanus vaccination-How much is too much?
Autorzy :
Priya PK; Post Graduate Junior Resident, Department of Community and Family Medicine, All India Institute of Medical Sciences, Raipur, India.
Parija PP; Senior Resident, Department of Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
Kujur A; Senior Resident, Department of Community and Family Medicine, All India Institute of Medical Sciences, Raipur, India.
Pokaż więcej
Źródło :
Tropical doctor [Trop Doct] 2021 Oct; Vol. 51 (4), pp. 492-496. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Journal Article
MeSH Terms :
Tetanus*/prevention & control
Humans ; India/epidemiology ; Infant, Newborn ; Tetanus Toxoid ; Vaccination ; World Health Organization
Czasopismo naukowe
Tytuł :
Post-exposure Rabies Prophylaxis for Children in Southern Turkey.
Autorzy :
Celiloglu C; Department of Pediatrics, University of Medical Sciences, Adana City Training and Research Hospital, Adana, Turkey.
Özdemİr U; Department of Pediatrics, University of Medical Sciences, Adana City Training and Research Hospital, Adana, Turkey.
Tolunay O; Department of Pediatrics, University of Medical Sciences, Adana City Training and Research Hospital, Adana, Turkey.
Sucu A; Department of Pediatrics, University of Medical Sciences, Adana City Training and Research Hospital, Adana, Turkey.
Celik U; Department of Pediatrics, University of Medical Sciences, Adana City Training and Research Hospital, Adana, Turkey.
Pokaż więcej
Źródło :
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP [J Coll Physicians Surg Pak] 2021 Oct; Vol. 31 (10), pp. 1219-1223.
Typ publikacji :
Journal Article
MeSH Terms :
Rabies*/epidemiology
Rabies*/prevention & control
Animals ; Cats ; Child ; Cross-Sectional Studies ; Dogs ; Humans ; Patient Compliance ; Tetanus Toxoid ; Turkey/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies